RECCHIA, FABIO ANASTASIO
 Distribuzione geografica
Continente #
NA - Nord America 14.279
EU - Europa 11.337
AS - Asia 2.889
SA - Sud America 271
Continente sconosciuto - Info sul continente non disponibili 84
OC - Oceania 25
AF - Africa 23
Totale 28.908
Nazione #
US - Stati Uniti d'America 13.909
GB - Regno Unito 3.260
RU - Federazione Russa 2.311
UA - Ucraina 1.268
IT - Italia 1.246
DK - Danimarca 1.118
SG - Singapore 1.108
DE - Germania 997
CN - Cina 649
HK - Hong Kong 550
VN - Vietnam 443
SE - Svezia 415
CA - Canada 361
BR - Brasile 247
FI - Finlandia 217
IE - Irlanda 193
FR - Francia 119
EU - Europa 84
PL - Polonia 59
NL - Olanda 47
JP - Giappone 33
IN - India 27
CH - Svizzera 22
ID - Indonesia 18
AU - Australia 16
BE - Belgio 11
PT - Portogallo 11
RO - Romania 10
AT - Austria 9
NZ - Nuova Zelanda 9
TR - Turchia 9
IQ - Iraq 8
AR - Argentina 7
ES - Italia 7
BD - Bangladesh 6
EC - Ecuador 6
IR - Iran 6
KR - Corea 6
MX - Messico 6
PK - Pakistan 6
CO - Colombia 4
MA - Marocco 4
RS - Serbia 4
AO - Angola 3
EG - Egitto 3
GE - Georgia 3
LT - Lituania 3
PH - Filippine 3
ZA - Sudafrica 3
AZ - Azerbaigian 2
CI - Costa d'Avorio 2
HU - Ungheria 2
KE - Kenya 2
NG - Nigeria 2
PE - Perù 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
BA - Bosnia-Erzegovina 1
BG - Bulgaria 1
BO - Bolivia 1
CL - Cile 1
CZ - Repubblica Ceca 1
EE - Estonia 1
GA - Gabon 1
IL - Israele 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LB - Libano 1
LV - Lettonia 1
MD - Moldavia 1
NI - Nicaragua 1
NO - Norvegia 1
NP - Nepal 1
OM - Oman 1
PR - Porto Rico 1
PY - Paraguay 1
QA - Qatar 1
SA - Arabia Saudita 1
SD - Sudan 1
TH - Thailandia 1
TN - Tunisia 1
TW - Taiwan 1
UG - Uganda 1
UZ - Uzbekistan 1
Totale 28.908
Città #
Southend 2.638
Woodbridge 1.900
Ann Arbor 1.698
Chandler 1.253
Houston 1.134
Fairfield 793
San Mateo 790
Dearborn 657
Jacksonville 630
Falls Church 455
Seattle 449
Hong Kong 447
Singapore 443
Cambridge 384
Wilmington 382
Beijing 366
Wayne 330
Ashburn 317
Boardman 260
Dong Ket 255
Moscow 254
Stevenage 252
Portsmouth 219
Lawrence 208
Pisa 189
Dublin 174
Beauharnois 121
Ottawa 121
Redwood City 118
Montréal 91
Brooklyn 83
Guangzhou 76
San Diego 70
Old Bridge 69
Santa Clara 55
Rome 54
Warsaw 51
Milan 45
Norwalk 40
London 35
Munich 28
Council Bluffs 24
São Paulo 24
Florence 23
Tokyo 23
Fremont 21
Cascina 20
Helsinki 20
Foggia 18
Buti 17
Caserta 14
Genoa 14
Paris 14
Livorno 13
Selargius 13
Shenzhen 13
Augusta 12
Kunming 12
Los Angeles 12
San Giuliano Terme 12
West Jordan 12
Hanover 11
Brasília 10
Nuremberg 10
Philadelphia 10
Provo 10
Washington 10
Nanjing 9
New York 9
Osaka 9
Salerno 9
The Dalles 9
Chicago 8
Chiswick 8
Islington 8
Lyon 8
Mountain View 8
Toronto 8
Traverse City 8
Turin 8
Berlin 7
Brussels 7
Freiburg im Breisgau 7
Padova 7
Parma 7
Rimini 7
Siena 7
Ypsilanti 7
Bologna 6
Dongguan 6
Frankfurt am Main 6
Melbourne 6
Naples 6
Nürnberg 6
San Antonio 6
Simi Valley 6
Baghdad 5
Belo Horizonte 5
Curitiba 5
Gdynia 5
Totale 18.559
Nome #
Magnetic resonance imaging of infarct-induced canonical wingless/integrated (Wnt)/β-catenin/T-cell factor pathway activation, in vivo. 287
3D CMR Mapping of Metabolism by Hyperpolarized 13C-Pyruvate in Ischemia–Reperfusion 239
A new dual-promoter system for cardiomyocyte-specific conditional induction of apoptosis 229
Surgical Access and Stimulation of the Pig Pudendal Nerve to Restore Bladder Dysfunctions 216
Analysis of Serum Cholesterol Efflux Capacity in a Minipig Model of Nonischemic Heart Failure 207
Cardiac adeno-associated virus 9-mediated delivery of nestin-640 prevents myocardial remodeling in a rodent model of post-ischemic heart failure 203
A Dose-Response Elevation in Hepatic Glucose Uptake is Paralleled by Liver Triglyceride Synthesis and Release. 202
Molecular Advances in Reporter Genes: The Need to Witness the Function of Stem Cells in Failing Heart in Vivo. 202
Enabling MSI-Guided Laser Capture Microdissection 201
An Implantable ZigBee Ready Telemetric Platform For In Vivo Monitoring Of Physiological Parameters 198
Multimodal molecular imaging system for pathway-specific reporter gene expression 194
MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs 194
Real time cardiac metabolism assessed with hyperpolarized [1-13C] acetate in a large animal model 186
DNP methods for cardiac metabolic imaging with hyperpolarized [1-13C]pyruvate large dose injection in pigs 185
Expression of C-type natriuretic peptide and of its receptor NPR-B in normal and failing heart. 184
REGIONAL MAPPING OF MYOCARDIAL HIBERNATION PHENOTYPE IN IDIOPATHIC END-STAGE DILATED CARDIOMYOPATHY 181
Modulating Fatty Acid Oxidation in Heart Failure 178
Acute vagal stimulation attenuates cardiac metabolic response to beta-adrenergic stress. 176
Acetylation mediates Cx43 reduction caused by electrical stimulation 176
Proteomics-based network analysis characterizes biological processes and pathways activated by preconditioned mesenchymal stem cells in cardiac repair mechanisms 175
Cardiovascular Molecular Imaging with Hyperpolarized [1-13C] acetate and [1-13C] pyruvate in middle size animal model 173
Placental stem cells pre-treated with hyaluronan-butyric-retinoic ester to cure infarcted pig hearts: a multimodal study. 172
Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5T cardiac MRI in a rat model of myocardial infarction 169
Low HDL - high inflammatory markers in heart failure induced by high frequency pacing in minipigs. 166
Glucose-6-Phosphate Dehydrogenase Deficiency Increases Myocardial Redox Stress and Moderately Accelerates the Development of Heart Failure 163
Carnitine palmitoyl transferase-I inhibition prevents ventricular remodeling and delays decompensation in pacing-induced heart failure 162
Pathogenic role of mitochondrial calcium uniporter upregulation in the failing heart: Ca2+ mishandling or what else? 161
Altered cardiac metabolic phenotype after prolonged inhibition of NO synthesis in chronically instrumented dogs. 159
Diverse protein kinase A-dependent myofilament protein phosphorylation in the background of regional contractile dysfunction in pacing-induced heart failure 159
Severe mechanical dyssynchrony causes regional hibernation-like changes in pigs with nonischemic heart failure. 159
Beneficial effects of acute inhibition of the oxidative pentose phosphate pathway in the failing heart. 158
Chronic inhibition of nitric oxide synthase alters cardiac substrate handling: underestimating changes in metabolism. 158
AAV-Mediated Delivery of VEGF-B Preserves Viability and Cardiac Function Following Myocardial Infarction through a Direct Effect on Cardiomyocyte Survival and Contractility 157
Glucose-6-phosphate dehydrogenase-derived NADPH fuels superoxide production in the failing heart. 154
Reduced cardiac NO production during pacing-induced heart failure 154
Adeno-associated virus mediated gene delivery into coronary microvessels of chronically instrumented dogs. 153
Pathologic pulse pressure in isolated coronary artery bed augments flow in vivo despite constant ventricular workload 153
Reduced synthesis of NO causes marked alterations in myocardial substrate metabolism in conscious dogs 152
Sequencing and cardiac expression of natriuretic peptide receptor 2 (NPR-B) in Sus Scrofa. 152
Impact of glucose-6-phosphate dehydrogenase deficiency on the pathophysiology of cardiovascular disease. 152
Gene Therapy for Heart Failure: New Perspectives 152
Systolic flow augmentation in hearts ejecting into a model of stiff aging vasculature. Influence on myocardial perfusion-demand balance. 151
In vitro system to study realistic pulsatile flow and stretch signaling in cultured vascular cells 150
Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodeling in rats. 150
A partial knockdown of glucose-6-phosphate dehydrogenase impairs cardiac contractile performance and efficiency, in vivo 150
Acute NO synthase inhibition profoundly alters myocardial oxidation of free fatty acids and glucose in conscious dogs 150
Enhanced caveolae-mediated endocytosis by diagnostic ultrasound in vitro. 149
Mismatch between uniform increase in cardiac glucose uptake and regional contractile dysfunction in pacing-induced heart failure. 149
Segmental analysis of cardiac metabolism by hyperpolarized [1-13C] pyruvate: an in-vivo 3D MRI study in pigs 149
LOW HDL-HIGH INFLAMMATORY MARKERS IN HEART FAILURE INDUCED BY HIGH FREQUENCY PACING IN MINIPIGS 148
Nestin is a key regulator of cardioprotection and nestin-640 gene therapy rescues infarcted myocardium 147
Water-Dispersible Three-Dimensional LC-Nanoresonators 147
Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH. 146
Abnormal stress-induced myocardial metabolic changes in patients with dilated cardiomyopathy. 146
Follistatin-like 1 promotes cardiac fibroblast activation and protects the heart from rupture 146
Animal models of dilated cardiomyopathy for translational research. 145
Transthoracic Sensor for Noninvasive Assessment of Left Ventricular Contractility: Validation in A Minipig Model of Chronic Heart Failure. 145
Control of autocrine and paracrine myocardial signals: an emerging therapeutic strategy in heart failure. 145
Q-PINE: A quick to implant peripheral intraneural electrode 145
Paradoxical downregulation of the glucose oxidation pathway despite enhanced flux in severe heart failure. 144
Impaired myocardial metabolic reserve and substrate selection flexibility during stress in patients with idiopathic dilated cardiomyopathy. 144
Early detection of acute lung injury uncoupled to hypoxemia in pigs using ultrasound lung comets. 144
Hyaluronan mixed esters of butyric and retinoic acid affording myocardial survival and repair without stem cell transplantation. 144
Nitric oxide-mediated arteriolar dilation after endothelial deformation 143
Adverse influence of systemic vascular stiffening on cardiac dysfunction and adaptation to acute coronary occlusion. 143
Reduced left ventricular compliance and mechanical efficiency after prolonged inhibition of NO synthesis in conscious dogs. 143
Upregulation of glucose-6-phosphate dehydrogenase and NAD(P)H oxidase activity increases oxidative stress in failing human heart. 143
A novel endothelial mechanism that counteracts arteriolar constriction. 143
Evaluation of the expression of transcripts coding for CNP and for its specific receptor NPR-B by Real Time PCR in cardiac tissue of normal and heart failure animals 142
Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy 142
Intracoronary Cytoprotective Gene Therapy: A Study of VEGF-B167 in a Pre-Clinical Animal Model of Dilated Cardiomyopathy 142
Class I histone deacetylase inhibition for the treatment of sustained atrial fibrillation 142
Acute and chronic endothelial dysfunction: implications for the development of heart failure. 141
Acute NO synthase inhibition increases the activities of myocardial glyceraldehyde-3-phosphate-dehydrogenase and malonyl-CoA-decarboxylase in conscious dogs. 141
Early long‐term L‐T3 replacement rescues mitochondria and prevents ischemic cardiac remodeling in rats 141
Kinin-mediated coronary nitric oxide production contributes to the therapeutic action of angiotensin-converting enzyme and neutral endopeptidase inhibitors and amlodipine in the treatment in heart failure. 140
Combined PET and Tagging-MRI reveal altered patterns of regional function and metabolism in ventricular dyssynchrony. 140
Short Interfering RNA-Mediated Knockdown Of Glucose-6-Phosphate Dehydrogenase Impairs Cardiac Contractile Performance and Efficiency in Conscious Dogs. 140
Altered metabolic response to exercise in the eNOS knockout mice. 140
The rate of tension redevelopment is not modulated by sarcomere length in permeabilized human, murine and porcine cardiomyocytes. 139
Overview of ventilator-induced lung injury mechanisms 139
Changes in cardiac metabolism produced by acute inhibition of NO synthase can be reversed by a long-acting NO donor 139
ACE-inhibitor, modulates myocardial glucose uptake via B2-kinin receptor-mediated cardiac NO production in Langendorff mouse heart. 139
Amlodipine releases nitric oxide (NO) from coronary microvessels after pacing induced dilated cardiomyopathy. 139
Endothelial function and vascular oxidative stress in long-lived GH/IGF-deficient Ames dwarf mice. 138
Reduced nitric oxide production and altered myocardial metabolism during the decompensation of pacing-induced heart failure in the conscious dog. 138
Modulation of caveolar trafficking of endothelial cells by diagnostic cardiac ultrasound. 138
Stem cells transduction with ferritin as a reporter gene to track their fate by 1.5 Tesla MRI, in the beating heart. 138
CELL-TO-CELL VARIABILITY IN TROPONIN I PHOSPHORYLATION IN A PORCINE MODEL OF PACING-INDUCED HEART FAILURE 138
Early mechanical dyssynchrony induced by unipolar left ventricular pacing is unrelated to myocardial flow and metabolism 138
Pacing induced myocardial ischemia in patients with dilated cardiomyopathy. 138
Adaptation and optimization of an intraneural electrode to interface with the cervical vagus nerve 138
NO METABOLITES ACCUMULATE IN ERYTHROCYTES IN PROPORTION TO CARBON DIOXIDE AND BICARBONATE CONCENTRATION. 137
Cardiac endocrine function is an essential component of the homeostatic regulation network: physiological and clinical implications 137
Selective alteration in cardiac glucose oxidation after prolonged inhibition of NO synthesis in conscious dogs 137
Cardiac Metabolism in a Pig Model of Ischemia-Reperfusion by Cardiac Magnetic Resonance with Hyperpolarized 13C-Pyruvate 137
Acute and Chronic Increases of Circulating FSTL1 Normalize Energy Substrate Metabolism in Pacing-Induced Heart Failure 136
Pre-treatment of human mesenchymal stem cells with a chemical inductor of cardiogenesis increases their effects on regional myocardial function in a swine model of myocardial infarction. 135
The activation of glucose 6-phosphate dehydrogenase as a source of substrate for NADPH oxidase in the failing heart 135
Hyaluronan mixed esters of butyric and retinoic acid drive cardiac and endothelial fate in term placenta human mesenchymal stem cells and enhance cardiac repair in infarcted rat hearts. 135
Totale 15.739
Categoria #
all - tutte 151.202
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 151.202


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020392 0 0 0 0 0 0 0 0 0 41 54 297
2020/20214.555 156 651 312 338 433 578 291 197 278 274 433 614
2021/20223.340 170 615 419 278 65 61 315 592 162 323 81 259
2022/20232.877 233 126 48 605 366 469 36 235 481 69 110 99
2023/20241.082 151 66 203 58 65 161 133 31 13 36 42 123
2024/20255.054 79 62 416 237 188 512 1.024 1.924 552 60 0 0
Totale 29.084